Wells Fargo’s Third Harmonic Bio THRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$87.5K Buy
16,118
+2,962
+23% +$16.1K ﹤0.01% 4866
2025
Q1
$45.7K Buy
13,156
+1,519
+13% +$5.27K ﹤0.01% 4983
2024
Q4
$120K Buy
11,637
+2,535
+28% +$26.1K ﹤0.01% 4614
2024
Q3
$123K Buy
9,102
+391
+4% +$5.3K ﹤0.01% 4498
2024
Q2
$113K Buy
8,711
+1,850
+27% +$24.1K ﹤0.01% 4501
2024
Q1
$64.8K Buy
6,861
+885
+15% +$8.35K ﹤0.01% 4776
2023
Q4
$65.6K Buy
5,976
+1,183
+25% +$13K ﹤0.01% 4743
2023
Q3
$30.6K Sell
4,793
-2,570
-35% -$16.4K ﹤0.01% 5064
2023
Q2
$35.4K Buy
7,363
+5,042
+217% +$24.3K ﹤0.01% 5277
2023
Q1
$9.56K Buy
+2,321
New +$9.56K ﹤0.01% 5559